Cite
HARVARD Citation
Fumery, M. et al. (2021). Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study. Journal of Crohn's and colitis. pp. 222-227. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fumery, M. et al. (2021). Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study. Journal of Crohn's and colitis. pp. 222-227. [Online].